Combined Hepatocellular-Cholangiocarcinoma Patient Treated with Durvalumab Plus Gemcitabine and Cisplatin: A Case Report.
증례보고
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
추출되지 않음
I · Intervention 중재 / 시술
durvalumab plus gemcitabine and cisplatin (Dur/GC)
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
After treatment, the patient developed grade 2 diarrhea and grade 3 thrombocytopenia. CT after one course of Dur/GC demonstrated tumor shrinkage and expanded peritoneal dissemination, suggesting the need for further studies on the efficacy and safety of this therapy for unresectable cHCC-CCA.
A 55-year-old man with lower abdominal pain and diarrhea was referred to our hospital.
APA
Kobayashi D, Hayashi M, et al. (2026). Combined Hepatocellular-Cholangiocarcinoma Patient Treated with Durvalumab Plus Gemcitabine and Cisplatin: A Case Report.. Internal medicine (Tokyo, Japan). https://doi.org/10.2169/internalmedicine.6512-25
MLA
Kobayashi D, et al.. "Combined Hepatocellular-Cholangiocarcinoma Patient Treated with Durvalumab Plus Gemcitabine and Cisplatin: A Case Report.." Internal medicine (Tokyo, Japan), 2026.
PMID
41850826 ↗
Abstract 한글 요약
A 55-year-old man with lower abdominal pain and diarrhea was referred to our hospital. Computed tomography (CT) revealed a hypovascular liver tumor, lymph node/bone metastases, and peritoneal dissemination. Based on a histological analysis of lymph node metastasis, he was diagnosed with combined hepatocellular-cholangiocarcinoma (cHCC-CCA) and received durvalumab plus gemcitabine and cisplatin (Dur/GC). After treatment, the patient developed grade 2 diarrhea and grade 3 thrombocytopenia. CT after one course of Dur/GC demonstrated tumor shrinkage and expanded peritoneal dissemination, suggesting the need for further studies on the efficacy and safety of this therapy for unresectable cHCC-CCA.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (2)
- A method for identifying neoantigens through isolation of circulating tumor cells using apheresis among patients with advanced-stage cancer.
- Data-Independent Acquisition (DIA)-Based Label-Free Redox Proteomics (DIALRP) Identifies Prominent Cysteine Oxidations in Translation Machinery in Prostate Cancer Cells Under Oxidative Stress.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Multicenter Validation Study of the Clinical Diagnostic Criteria for IgG4-Related Sclerosing Cholangitis 2020 in Japan.
- Actionable genomic landscape of biliary tract cancer in the Indian population.
- Integrin αvβ3 is a Potential Therapeutic Target in Cholangiocarcinoma.
- Ferroptosis in Cholangiocarcinoma Therapy: Molecular Mechanisms, Pharmacological Modulation and Opportunities for Drug Development.
- Stratifying cholangiocarcinoma: tumor microenvironment, molecular drivers, and novel immunotherapeutic approaches.
- A case of perihilar cholangiocarcinoma with peritoneal dissemination that achieved a pathological complete response using immune checkpoint inhibitors: A case report.